InnovaHealth Partners

www.innovahealthpartners.com

VCMatch tracks InnovaHealth Partners as an investor focused on Medtech, Digital Health, and Healthtech companies, Growth and Late Stage rounds, and United States, Europe, and Israel markets. Upload your deck to compare your startup against the full private matching profile.

Check Size

Not specified

Stages

Growth, Late Stage

Focus Areas

Medtech, Digital Health, Healthtech

Geography

United States, Europe, and Israel

Investment Thesis

InnovaHealth Partners is a sector-focused, research-driven private equity firm that seeks to create value by partnering with management teams to scale established, high-growth medical device companies. The firm targets later-stage, disruptive medical technologies that address large unmet clinical and surgical needs globally and combines capital with strategic insight, regulatory and reimbursement expertise, and industry relationships to accelerate growth and improve patient outcomes.

Is InnovaHealth Partners right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

InnovaHealth Partners is most relevant for founders raising Growth and Late Stage rounds in Medtech, Digital Health, and Healthtech, especially across United States, Europe, and Israel.

Focus statement

InnovaHealth Partners is a New York City-based investment firm concentrating on growth buyouts of established medical technology companies, targeting opportunities primarily in the United States, Europe and Israel and aiming to acquire controlling positions as the sole or lead investor.

Value Add

Research-first approach: "Research has been core to the InnovaHealth franchise for well over 20 years," giving the firm "unique insight and privileged access to information about the medical device industry and its trends."
Deep sector specialization in medical devices and large, established growth buyouts (later-stage opportunities and disruptive technologies).
Experienced, long-tenured team with collective industry experience ("over 100 years of experience investing in the medical device space" and team members who have worked together for 15–20+ years).
Operational and strategic support beyond capital: leveraging "longstanding relationships with strategic acquirers, clinical and scientific advisors, regulatory and reimbursement experts and industry executives."
Global deal scope focused on major medtech markets (United States, Europe and Israel) and a demonstrated track record of exits/strategic sales (portfolio companies now part of Stryker, Smith & Nephew, Henry Schein, Wright Medical, etc.).